WELL Health Technologies Corp. (TSX:WELL)
Canada flag Canada · Delayed Price · Currency is CAD
4.040
+0.040 (1.00%)
Jul 31, 2026, 4:00 PM EST

WELL Health Technologies Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,4741,400919.69776.05569.14302.32
Revenue Growth
48.87%52.24%18.51%36.36%88.25%501.76%
Gross Profit
664.54618.84363.01372.27303.29153.7
Operating Income
8578.49-30.235.1623.31-13.29
Net Income
26.83-7.3632.610.081.37-44.18
Earnings Per Share
0.11-0.030.13---0.23
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Canadian Patient Services - Primary WMC
302.54279.24191.89119.2177.83-
Canadian Patient Services - Specialized WDC
173.59166.52127.56111.32104.2442.46
WELL Health USA Patient Services - Primary Circle Medical
151.42145.176.396.6269.4-
WELL Health USA Patient Services - Primary WISP
114.61115.03100.9777.8858.18-
WELL Health USA Patient Services - Specialized CRH Medical
298.14293.61234.72249.42202.14132.5
WELL Health USA Patient Services - Specialized-Provider Staffing
208.08214.21123.1355.42--
Saas and Technology Services
87.786.5772.8773.1860.96-
Healwell
-113.56----
Corporate/Eliminations
27.8220.6615.916.9414.3915.24
Inter-Segment
-36.49-34.32-23.65-23.93-18.01-17.24
Total
1,4741,400919.69776.05569.14302.32

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
134133.76131.6743.4248.9161.92
Total Debt
673.03600.65425.09426.28358.42401.94
Net Cash (Debt)
-539.03-466.89-293.42-382.86-309.51-340.02
Net Cash Growth
------
Net Cash Per Share
-2.12-1.85-1.15-1.62-1.40-1.78

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
115.51121.899.5266.4476.5522.27
Capital Expenditures
-32.64-27.87-16.23-8.11-6.4-2.68
Free Cash Flow
82.8794.02-6.758.3370.1419.59
Free Cash Flow Growth
803.26%---16.84%258.12%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.07%44.20%39.47%47.97%53.29%50.84%
Operating Margin
5.77%5.61%-3.28%4.53%4.10%-4.39%
Pretax Margin
2.82%0.38%0.98%2.51%3.08%-8.43%
Profit Margin
2.78%0.32%3.16%2.14%3.28%-10.35%
FCF Margin
5.62%6.71%-0.73%7.52%12.32%6.48%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
38.23-52.77---
Forward PE
17.8541.96226.40196.02196.02196.02
P/FCF Ratio
14.6210.78-15.949.3552.43
PS Ratio
0.700.721.861.201.153.40